StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.35−0.14 (-9.40%)

Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –

Actinium Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Actinium Pharmaceuticals's price to book ratio was 1.6× on Nov 11, 2026, against 3.1× a year earlier. Over the last 5 years it ranged from 0.9× to 17.2×, with a median of 2.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×−1.4
2025Dec 31, 20253.1×+2.0
2024Dec 31, 20241.0×−2.2
2023Dec 29, 20233.2×−0.6
2022Dec 30, 20223.8×+2.1
2021Dec 31, 20211.6×−0.7
2020Dec 31, 20202.3×−1.3
2019Dec 31, 20193.6×−0.1
2018Dec 31, 20183.7×+0.8
2017Dec 29, 20172.9×−0.0
2016Dec 30, 20162.9×−3.0
2015Dec 31, 20155.9×−67.6
2014Dec 31, 201473.6×−157.0
2013Dec 31, 2013230.6×–

More Actinium Pharmaceuticals figures

See a number that looks wrong?